Tiny study asks: does aspirin work in patients with low platelets?

NCT ID NCT04912505

Completed Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well a daily low-dose aspirin works in people who have both immune thrombocytopenia (low platelets) and heart disease. Only 4 adults took part. Researchers measured platelet function after aspirin to see if the standard dose is enough to prevent blood clots. The study is complete, but the small size means the findings are very limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Aspirin
What this could lead to: If successful, this could help doctors understand if standard aspirin dosing is enough to protect against blood clots in people with immune thrombocytopenia.
What could go wrong: This was a very small, early-phase study with only 4 participants, so results may not apply to everyone. The study is already completed, and no new treatment is being tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder Purpura, Thrombocytopenic, Idiopathic thrombocytopenia due to immune destruction thrombocytopenic purpura

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PURPURA, THROMBOCYTOPENIC

Contacts and locations

Locations

Toulouse Hospital

Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.